InvestorsHub Logo
Followers 126
Posts 13397
Boards Moderated 10
Alias Born 11/18/2009

Re: None

Monday, 04/05/2010 8:52:16 PM

Monday, April 05, 2010 8:52:16 PM

Post# of 70
CLRT--Alright, just when I thought nothing juicy would come through today, this came through. Insider buy, 50,000 shares at $2.44. Stock is currently trading at $2.71 (at close today). This stock has traded as high as $4.43 this year, is closer to the low than the high of the year. Has a 53 million share float! Nice Nasdaq stock. I will be adding in the morning. Remember do your own DD. We are just posting our pics that meet OUR trading matrix that have insider purchases.

Insider information provided by www.scumfish.com

Losing

Clarient, Inc. (Clarient) is an oncology diagnostics services company. It provides diagnostic services that assess and characterize cancer for physicians treating their patients, as well as for biopharmaceutical companies in the process of clinically testing various therapies. As of December 31, 2009, its services were provided within the United States. Clarient provides a range of oncology diagnostic testing and consultative services, which include technical laboratory services and interpretation of laboratory test results by physicians that specialize in pathology, such reports and analyses primarily are provided to it customers through its Internet-based portal, PATHSiTE.